These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9113511)

  • 1. HER2-targeted gene transfer.
    Foster BJ; Kern JA
    Hum Gene Ther; 1997 Apr; 8(6):719-27. PubMed ID: 9113511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1.
    Kern JA; Wakita R; Sliwkowski MX
    Cancer Gene Ther; 1999; 6(6):537-45. PubMed ID: 10608350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine.
    Chiu SJ; Ueno NT; Lee RJ
    J Control Release; 2004 Jun; 97(2):357-69. PubMed ID: 15196762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
    Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
    Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer.
    Coll JL; Wagner E; Combaret V; Metchler K; Amstutz H; Iacono-Di-Cacito I; Simon N; Favrot MC
    Gene Ther; 1997 Feb; 4(2):156-61. PubMed ID: 9081706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced efficiency of lactosylated poly-L-lysine-mediated gene transfer into cystic fibrosis airway epithelial cells.
    Kollen WJ; Schembri FM; Gerwig GJ; Vliegenthart JF; Glick MC; Scanlin TF
    Am J Respir Cell Mol Biol; 1999 May; 20(5):1081-6. PubMed ID: 10226080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors.
    Germershaus O; Merdan T; Bakowsky U; Behe M; Kissel T
    Bioconjug Chem; 2006; 17(5):1190-9. PubMed ID: 16984128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
    Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
    Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated gene delivery for B-cell lymphoma in vitro.
    Schachtschabel U; Pavlinkova G; Lou D; Köhler H
    Cancer Gene Ther; 1996; 3(6):365-72. PubMed ID: 8988839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluconoylated and glycosylated polylysines as vectors for gene transfer into cystic fibrosis airway epithelial cells.
    Kollen WJ; Midoux P; Erbacher P; Yip A; Roche AC; Monsigny M; Glick MC; Scanlin TF
    Hum Gene Ther; 1996 Aug; 7(13):1577-86. PubMed ID: 8864758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
    Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
    Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells.
    Mann K; Kullberg M
    Cancer Gene Ther; 2016 Jul; 23(7):221-8. PubMed ID: 27199219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody.
    Kern JA; Torney L; Weiner D; Gazdar A; Shepard HM; Fendly B
    Am J Respir Cell Mol Biol; 1993 Oct; 9(4):448-54. PubMed ID: 8104437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells.
    Marches R; Uhr JW
    Int J Cancer; 2004 Nov; 112(3):492-501. PubMed ID: 15382077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.
    Dou S; Yao YD; Yang XZ; Sun TM; Mao CQ; Song EW; Wang J
    J Control Release; 2012 Aug; 161(3):875-83. PubMed ID: 22762887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific anti-HER2 and CD16 single-chain antibody production prolongs the use of stem cell-like cell transplantation against HER2-overexpressing cancer.
    Kasuya K; Shimazu M; Suzuki M; Itoi T; Aoki T; Tsuchida A
    Int J Mol Med; 2010 Feb; 25(2):209-15. PubMed ID: 20043129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
    Huang H; Yu H; Tang G; Wang Q; Li J
    Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.